SERVICES FOR VENTURE CAPITAL FUNDS AND OTHER INVESTMENT FIRMS:

• Perform due-diligence on pharmaceutical firms, potential drugs and/or CROs.

• Provide guidance on regulatory consequences of specific toxicology findings.

• Advise on implications of regulatory agency requests regarding preclinical issues.

• Advise on current industry trends in toxicology and nonclinical CROs.